Thalys Medical Technology Group Inc
SSE:603716

Watchlist Manager
Thalys Medical Technology Group Inc Logo
Thalys Medical Technology Group Inc
SSE:603716
Watchlist
Price: 20.55 CNY -1.91% Market Closed
Market Cap: 4.3B CNY

Intrinsic Value

The intrinsic value of one Thalys Medical Technology Group Inc stock under the Base Case scenario is 8.68 CNY. Compared to the current market price of 20.55 CNY, Thalys Medical Technology Group Inc is Overvalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
8.68 CNY
Overvaluation 58%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Thalys Medical Technology Group Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Thalys Medical Technology Group Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Thalys Medical Technology Group Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Thalys Medical Technology Group Inc.

Explain Valuation
Compare Thalys Medical Technology Group Inc to

Fundamental Analysis

Thalys Medical Technology Group Inc
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Thalys Medical Technology Group Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Thalys Medical Technology Group Inc

Current Assets 1.4B
Receivables 946m
Other Current Assets 436m
Non-Current Assets 708m
Long-Term Investments 287m
PP&E 135m
Intangibles 74m
Other Non-Current Assets 212m
Current Liabilities 1B
Accounts Payable 300m
Accrued Liabilities 26m
Short-Term Debt 322m
Other Current Liabilities 357m
Non-Current Liabilities -6m
Long-Term Debt 22m
Other Non-Current Liabilities -28m
Efficiency

Free Cash Flow Analysis
Thalys Medical Technology Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Thalys Medical Technology Group Inc

Revenue
1.2B CNY
Cost of Revenue
-1B CNY
Gross Profit
227.9m CNY
Operating Expenses
-339.4m CNY
Operating Income
-111.5m CNY
Other Expenses
-129m CNY
Net Income
-240.5m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Thalys Medical Technology Group Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
27/100
Profitability
Score

Thalys Medical Technology Group Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Thalys Medical Technology Group Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
64/100
Solvency
Score

Thalys Medical Technology Group Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Thalys Medical Technology Group Inc

There are no price targets for Thalys Medical Technology Group Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Thalys Medical Technology Group Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Thalys Medical Technology Group Inc stock?

The intrinsic value of one Thalys Medical Technology Group Inc stock under the Base Case scenario is 8.68 CNY.

Is Thalys Medical Technology Group Inc stock undervalued or overvalued?

Compared to the current market price of 20.55 CNY, Thalys Medical Technology Group Inc is Overvalued by 58%.

Back to Top